Non-Invasive Monitoring Systems, Inc. (NIMS), a company previously engaged in the development and marketing of non-invasive therapeutic platforms, has released its Form 10-K report for the fiscal year ended July 31, 2023. The report provides a comprehensive overview of the company's financial performance, operational status, strategic initiatives, and the challenges it faces as it navigates its current status as a shell company.
Financial Highlights
- Operating Loss: $169,000. The operating loss for the year ended July 31, 2023, increased by $10,000 compared to the previous year, primarily due to higher general and administrative expenses.
- Net Loss: $199,000. The net loss for the year ended July 31, 2023, increased by $26,000 compared to the previous year, mainly due to increased interest expenses and professional fees.
- Net Income Per Share: $(0.00). The basic and diluted loss per common share remained unchanged at $(0.00) for both years ended July 31, 2023, and 2022.
Business Highlights
- Company Overview: Non-Invasive Monitoring Systems, Inc. (NIMS) was primarily engaged in the development, manufacture, and marketing of non-invasive, whole body periodic acceleration (WBPA) therapeutic platforms. However, the company discontinued these operations in May 2019 and is currently classified as a shell company.
- Discontinued Operations: The company has no inventory or products available for sale following the discontinuation of its operations in 2019. The assets and liabilities related to these operations are classified as discontinued.
- Future Outlook: NIMS is exploring potential mergers and acquisitions as part of its strategic plan to revitalize its business operations. The company is actively seeking opportunities for strategic collaborations to ensure its future viability.
- Liquidity and Capital Resources: The company's operations have been primarily financed through private sales of equity securities and notes from related parties. As of July 31, 2023, NIMS had cash reserves of $7,000 and negative working capital of approximately $268,000, indicating a need for additional financing to sustain operations over the next twelve months.
- Management's Discussion: The management has highlighted the need for additional capital to support potential mergers and acquisitions. The company acknowledges the challenges posed by current economic conditions, which may impact its ability to secure necessary funding.
Strategic Initiatives
- Mergers and Acquisitions: The company is actively seeking potential mergers and acquisitions to enhance its strategic positioning. This initiative is part of a broader plan to explore strategic collaborations that could provide new growth opportunities.
- Capital Management: The company has been managing its capital through private sales of equity securities and notes from related parties. It entered into a Promissory Note for $200,000 with Frost Gamma Investments Trust, with an interest rate of 11% per annum, payable by July 31, 2025. Additionally, the company has been involved in related party transactions to secure financing, including promissory notes with key stakeholders.
- Future Outlook: The company acknowledges the need to raise additional capital to support its operations and strategic initiatives. It is exploring various financing options, although there is no assurance that such capital will be available on favorable terms. The company remains focused on identifying and executing strategic mergers and acquisitions to drive future growth.
Challenges and Risks
- Operational Risks: The company has effectively discontinued operations since May 2019 and is currently a shell company, which poses significant operational risks as it lacks active business operations and inventory.
- Financial Condition: The company faces substantial risks related to its financial condition, including a history of operating losses and an accumulated deficit of $28.7 million as of July 31, 2023. The company has negative working capital and requires additional equity or debt financing to continue as a going concern. There is no assurance that such financing will be available on acceptable terms, or at all.
- Internal Controls: The company has identified material weaknesses in its internal controls over financial reporting, which could impair its ability to produce accurate financial statements on a timely basis. This poses a risk of potential misstatements and could affect investor confidence.
- Corporate Governance: The lack of an independent audit committee and compensation committee comprised of independent directors presents corporate governance risks, potentially compromising the management of the business and leading to conflicts of interest in management decisions.
- Liquidity Position: The company's liquidity position is precarious, with only $7,000 in cash and negative working capital of approximately $268,000 as of July 31, 2023. Continued economic volatility may limit access to necessary capital.
- Market Risk: General economic uncertainty and volatility in global equity and credit markets pose a risk to the company's ability to secure additional financing.
SEC Filing: